Advanced search
Publication Cover
Journal of Enzyme Inhibition and Medicinal Chemistry Volume 35, 2020 - Issue 1
Submit an article Journal homepage
2,989
Views
12
CrossRef citations to date
0
Altmetric
Research Paper

Design, synthesis, and biological evaluation of novel substituted thiourea derivatives as potential anticancer agents for NSCLC by blocking K-Ras protein-effectors interactions

Yuan ZhangTianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, ChinaView further author information
,
Xin MengTianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, ChinaView further author information
,
Haikang TangTianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, ChinaView further author information
,
Minghui ChengTianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, ChinaView further author information
,
Fujun YangTianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, ChinaView further author information
&
Wenqing XuTianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, ChinaCorrespondence[email protected]
View further author information
Pages 344-353 | Received 08 Jul 2019, Accepted 02 Dec 2019, Published online: 18 Dec 2019

References

  • Hancock JF, Paterson H, Marshall CJ. A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane. Cell 1990;63:133–9.
  • Malumbres M, Barbacid M. RAS oncogenes: the first 30 years. Nat Rev Cancer 2003;3:459–65.
  • Fernandez-Medarde A, Santos E. Ras in cancer and developmental diseases. Genes Cancer 2011;2:344–58.
  • Prior IA, Lewis PD, Mattos C. A comprehensive survey of Ras mutations in cancer. Cancer Res 2012;72:2457–67.
  • Castellano E, Santos E. Functional specificity of Ras isoforms: so similar but so different. Genes Cancer 2011;2:216–31.
  • Smith MJ, Neel BG, Ikura M. NMR-based functional profiling of RASopathies and oncogenic RAS mutations. Proc Natl Acad Sci USA 2013;110:4574–9.
  • Clausen R, Ma B, Nussinov R, Shehu A. Mapping the conformation space of wildtype and mutant H-Ras with a memetic, cellular, and multiscale evolutionary algorithm. PLoS Comput Biol 2015;11:e1004470.
  • Bos JL, Rehmann H, Wittinghofer A. GEFs and GAPs: critical elements in the control of small G proteins. Cell 2007;129:865–77.
  • Van Hattum H, Waldmann H. Chemical biology tools for regulating RAS signaling complexity in space and time. Chem Biol 2014;21:1185–95.
  • Antonoff MB, D'Cunha J. Non-small cell lung cancer: the era of targeted therapy. Lung Cancer (Auckl) 2012;3:31–41.
  • Forde PM, Ettinger DS. Targeted therapy for non-small-cell lung cancer: past, present and future. Expert Rev Anticancer Ther 2013;13:745–58.
  • Ostrem JM, Shokat KM. Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design. Nat Rev Drug Discov 2016;15:771–85.
  • Laraia L, McKenzie G, Spring DR, et al. Overcoming chemical, biological, and computational challenges in the development of inhibitors targeting protein-protein interactions. Chem Biol 2015;22:689–703.
  • Sun Q, Burke JP, Phan J, et al. Discovery of small molecules that bind to K-Ras and inhibit Sos-mediated activation. Angew Chem Int Ed Engl 2012;51:6140–3.
  • Maurer T, Garrenton LS, Oh A, et al. Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity. Proc Natl Acad Sci U S A 2012;109:5299–304.
  • Shimaa F, Yoshikawaa Y, Yea M, et al. In silico discovery of small-molecule Ras Inhibitors that display antitumor activity by blocking the Ras-effector interaction. Proc Natl Acad Sci U S A 2013;110:8182–7.
  • Hendricks MP, Campos MP, Cleveland GT, et al. A tunable library of substituted thiourea precursors to metal sulfide nanocrystals. Science 2015;348:1226–32.
  • Perry CJ, Holding K, Tyrrell E. Simple, novel synthesis for 1-carbamoyl-lH-benzotriazole and some of its analogs. Synth Commun 2008;38:3354–65.
  • Munch H, Hansen JS, Pittelkow M, et al. A new efficient synthesis of isothiocyanates from amines using di-tert-butyl dicarbonate. Tetrahedron Lett 2008;49:3117–9.
  • Hroch L, Guest P, Benek O, et al. Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer's disease treatment. Bioorg Med Chem 2017;25:1143–52.
  • Mohd Siddique MU, McCann GJ, Sonawane V, et al. Biphenyl urea derivatives as selective CYP1B1 inhibitors. Org Biomol Chem 2016;14:8931–6.
  • Kapanda CN, Masquelier J, Labar G, et al. Synthesis and pharmacological evaluation of 2,4-dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors. J Med Chem 2012;55:5774–83.
  • Chen L, Zhuang C, Lu J, et al. Discovery of novel KRAS-PDEdelta inhibitors by fragment-based drug design. J Med Chem 2018;61:2604–10.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.